Flezelastine hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFlezelastine hydrochloride
Drug Alias NameIDB-18024D-18024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsVoltage-gated calcium channel blockersArachidonate 5-lipoxygenase inhibitors
TargetsVoltage-gated calcium channelHistamine H1 receptorArachidonate 5-lipoxygenase
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeda AbAsta Medica AgNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsta Medica AgNational Cancer InstituteMeda Ab +[4] 
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A